Related Experiment Video
Updated: Nov 25, 2025
08:07
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.8K
Mesoporous Silica Nanoparticles as a Potential Platform for Vaccine Development against Tuberculosis
Sandra Montalvo-Quirós1,2, María Vallet-Regí3,4, Ainhoa Palacios5
1Department of Analytical Chemistry, Faculty of Chemistry, Complutense University of Madrid, 28040 Madrid, Spain.
Pharmaceutics
|December 19, 2020
Summary
Researchers developed novel nanosystems using mesoporous silica nanoparticles (MSNs) to mimic Mycobacterium tuberculosis (Mtb) extracellular vesicles. These MSNs effectively deliver immunomodulatory proteins, offering a promising strategy against tuberculosis.
Area of Science:
- Nanotechnology
- Immunology
- Microbiology
Background:
- Antibiotic-resistant Mycobacterium tuberculosis (Mtb) strains pose a significant global health threat.
- Mtb produces extracellular vesicles (EVs) with immunomodulatory proteins, previously considered for vaccines but limited by preparation variability.
- Developing stable, reproducible alternatives to Mtb EVs is crucial for novel therapeutic strategies.
Purpose of the Study:
- To engineer novel nanosystems that mimic Mtb-derived EVs.
- To utilize mesoporous silica nanoparticles (MSNs) as carriers for key immunomodulatory proteins (Ag85B, LprG, LprA).
- To evaluate the immunomodulatory capacity of these protein-functionalized MSNs.
Main Methods:
- Design and characterization of MSNs functionalized with Mtb-associated proteins (Ag85B, LprG, LprA) via covalent linkage.
- Assessment of protein anchorage effectiveness on the MSN surface.
- In vitro evaluation of immunostimulatory effects using macrophage cultures, measuring pro-inflammatory (TNF) and anti-inflammatory (IL-10) cytokine levels.
Main Results:
- Successfully designed and characterized MSNs displaying covalently anchored immunomodulatory proteins.
- Demonstrated the effectiveness of protein attachment to the MSN surface.
- Confirmed the immunostimulatory capacity of the nanosystems by observing modulated cytokine production (TNF and IL-10) in macrophages.
Conclusions:
- Developed a reproducible nanosystem mimicking Mtb EVs using MSNs and immunomodulatory proteins.
- The functionalized MSNs exhibit immunostimulatory properties, indicating potential therapeutic applications.
- These findings pave the way for advanced nanosystems combining immunomodulation and bactericidal effects against Mtb.
